Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of QuorumBusiness Wire • 09/25/26
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?The Motley Fool • 09/23/26
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special MeetingBusiness Wire • 09/23/26
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research • 09/17/26
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending StockZacks Investment Research • 09/16/26
Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 09/14/26
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?The Motley Fool • 09/14/26
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and FormulationsBusiness Wire • 09/08/26
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?Zacks Investment Research • 08/21/26
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD24/7 Wall Street • 08/19/26
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote NowBusiness Wire • 08/17/26
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?The Motley Fool • 08/16/26
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business GrowsBusiness Wire • 08/14/26